Investing First patient dosed in Phase IIb imaging for Brain Mets by admin April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post RHI: Acqn of royalty over Sandstone Gold Project tenements You may also like New Age Exploration July 8, 2025 Merger Discussions Between Brightstar and Aurumin June 30, 2025 7 Biggest Lithium-mining Companies in 2025 April 25, 2025 Editor’s Picks: Platinum Hits 11 Year High, Expert... June 29, 2025 Crypto Market Recap: ARK Invest Calls for Bitcoin... April 27, 2025 Sarama Outlines Extensive Gold Trends at Cosmo Gold... June 10, 2025 Satellite Imagery and Gold Exploration June 5, 2025 Ian Rodger Appointed Managing Director July 1, 2025 Athena Gold Upsizes Flow-Through Private Placement, Announces Concurrent... April 22, 2025 Adam Rozencwajg: Gold Stock Gains, Silver and Uranium... June 4, 2025